Search research articles
Contact Us
Filters
Showing results (161-170 of 199) with videos related to
Page
of 20
Sort By:
European Radiology
|
November 7, 2019
Facing privacy in neuroimaging: removing facial features degrades performance of image analysis methods
A de Sitter, M Visser, I Brouwer, et al.
The Lancet. Oncology
|
October 16, 2022
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
Zev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, et al.
The Lancet. Oncology
|
November 26, 2009
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
Andrew X Zhu, Jeffrey A Meyerhardt, Lawrence S Blaszkowsky, et al.
JCO Precision Oncology
|
January 12, 2023
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer
Rachel B Keller, Tali Mazor, Lynette Sholl, et al.
Nature Medicine
|
January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trial
Jun Tian, Jonathan H Chen, Sherry X Chao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2017
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)
Charles S Fuchs, Donna Niedzwiecki, Harvey J Mamon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study
Andrew X Zhu, Dushyant V Sahani, Dan G Duda, et al.
Cancer Research
|
July 4, 2012
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis
Austin M Dulak, Steven E Schumacher, Jasper van Lieshout, et al.
European Journal of Neurology
|
January 26, 2008
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study
C Wegner, M Filippi, T Korteweg, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab
Ryan J Park, Milan Parikh, Leon Pappas, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 199) with videos related to
Sort By:
Page
of 20
European Radiology
|
November 7, 2019
Facing privacy in neuroimaging: removing facial features degrades performance of image analysis methods
A de Sitter, M Visser, I Brouwer, et al.
The Lancet. Oncology
|
October 16, 2022
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
Zev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, et al.
The Lancet. Oncology
|
November 26, 2009
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
Andrew X Zhu, Jeffrey A Meyerhardt, Lawrence S Blaszkowsky, et al.
JCO Precision Oncology
|
January 12, 2023
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer
Rachel B Keller, Tali Mazor, Lynette Sholl, et al.
Nature Medicine
|
January 26, 2023
Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trial
Jun Tian, Jonathan H Chen, Sherry X Chao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2017
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)
Charles S Fuchs, Donna Niedzwiecki, Harvey J Mamon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study
Andrew X Zhu, Dushyant V Sahani, Dan G Duda, et al.
Cancer Research
|
July 4, 2012
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis
Austin M Dulak, Steven E Schumacher, Jasper van Lieshout, et al.
European Journal of Neurology
|
January 26, 2008
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study
C Wegner, M Filippi, T Korteweg, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab
Ryan J Park, Milan Parikh, Leon Pappas, et al.
Page
of 20